Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Zydus Cadila, a pharmaceutical company based in Ahmedabad, Gujarat, India, will begin conducting trials for a H1N1 vaccine.

Zydus Cadila Begins Clinical Development of H1N1 Vaccine

Theodore H. Meltzer is principle of Capitola Consultancy.

A comprehensive book about mass transfer benefits from the author's personal touch.

A Mass Transfer of Knowledge

There is a pressing need to improve the storage stability of currently available vaccines, and achieving this could facilitate mass vaccination campaigns and increase vaccination coverage on a global scale &#151; particularly to underserved and remote regions of the world.

Developing a vaccine that is stable at room temperature for 8 weeks

Hospira, a specialty pharmaceutical company, has agreed to acquire Orchid Chemicals' Pharmaceuticals for $400 million.

Hospira to Acquire Orchid's Generic Injectable Pharmaceutical Business

Also, Abbott to acquire Starlims Technologies; GSK Biologicals to form alliance with Intercell.

Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto Rico operations.

Novartis officially inaugurated its large-scale flu cell-culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina.

Novartis Inaugurates Flu Cell-Culture Vaccine Facility in North Carolina

Also, Merck & Co. extends collaboration with Idera Pharmaceuticals; Pfizer establishes R&D center in China; more...

Week of Nov. 30, 2009: Company and People Notes: BASF introduces new tablet-coating system; Catalent achieves ISO 15378 certification; and More.

Leading experts share insight on polymorphism and crystallization.

Solid-State Chemistry: A Technical Forum

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

Generic Drugs Come of Age

Manual sample preparation methods for solid dose pharmaceuticals have a number of inherent disadvantages, primarily because they are time consuming and unpredictable.